[Targeted cytotoxic drugs emerging for cancer therapy].;Vasta-aineisiin konjugoidut solunsalpaajat tulossa syövän hoitoon.

Duodecim; lääketieteellinen aikakauskirja

Volumn 127, Issue 4, 2011, Pages 343-349

  Junttila, Teemu T ^a   Tanner, Minna ^b   Isola, Jorma ^b  

^a GENENTECH INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BREAST TUMOR; FEMALE; HUMAN; MALE; NEOPLASM; REVIEW;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOCONJUGATES; MALE; NEOPLASMS;

EID: 79955037651     PISSN: 00127183     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)